Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02283216
Recruitment Status : Withdrawn (Lack of funding and personnel)
First Posted : November 5, 2014
Last Update Posted : May 1, 2019
Sponsor:
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute

Brief Summary:
The purpose of the study is to investigate different stimulation parameters for a new noninvasive approach for modulating the brain that could potentially be beneficial for decreasing tinnitus perception. The new approach is called Multimodal Synchronization Therapy (mSync). mSync uses a combination of acoustic stimulation played through headphones and low levels of electrical current delivered via electrodes placed on the surface of different body regions. The timing interval between the acoustic and body stimulation is varied in order to cause different types of changes in the brain. In addition to acoustic and body stimulation, noninvasive cortical stimulation will also be presented as part of mSync to attempt to further modulate or decrease the tinnitus percept. Cortical stimulation will be performed by placing a magnetic coil over a spot on the head and sending a brief magnetic pulse that can travel through the skin and bone to create electrical current inside the head. For this study, different body locations as well as specific timing intervals among acoustic, body, and cortical stimulation will be investigated to identify appropriate parameters that can modulate and potentially decrease tinnitus perception. Different mSync parameters will be investigated across multiple testing sessions (up to 16 weekly sessions) and the tinnitus percept will be closely monitored throughout the study.

Condition or disease Intervention/treatment Phase
Tinnitus Device: noise sound stimulation (Tucker-Davis Technologies) Device: body electrical stimulation (Digitimer device) Device: transcranial magnetic stimulation (Magstim) Not Applicable

Detailed Description:
This study is not specifically seeking to treat tinnitus but is designed to investigate various mSync parameters that can alter the tinnitus percept. Findings from this study will help identify specific mSync parameters that can be more effective at decreasing or fully suppressing the tinnitus percept that will be systematically explored in a follow-up study.

Layout table for study information
Study Type : Interventional
Actual Enrollment : 0 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Device Feasibility
Official Title: Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Actual Study Start Date : June 1, 2015
Actual Primary Completion Date : September 13, 2017
Actual Study Completion Date : September 13, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tinnitus

Arm Intervention/treatment
Experimental: Acoustic, Body, Cortical
Acoustic corresponds to noise sound stimulation. Body corresponds to body electrical stimulation. Cortical corresponds to transcranial magnetic stimulation. Acoustic is presented together with body and cortical stimulation. Different body locations and timing among acoustic, body, and cortical stimulation are presented across testing sessions.
Device: noise sound stimulation (Tucker-Davis Technologies)
Band-limited white noise stimulus, comfortable loudness level, presented via headphones or earphones with Tucker-Davis Technologies device.

Device: body electrical stimulation (Digitimer device)
Single pulse electrical stimulation on different body regions, comfortable current level, presented via surface pads or clips with Digitimer device.

Device: transcranial magnetic stimulation (Magstim)
Single pulse magnetic stimulation over frontal cortex, comfortable level at 110% resting motor threshold, presented via magnetic coil with Magstim device.




Primary Outcome Measures :
  1. Change in Tinnitus Functional Index Questionnaire Score [ Time Frame: Change from baseline score at 1 week after testing paradigm ]
    A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score.

  2. Change in Minimal Masking Level [ Time Frame: Change in baseline level at an expected average of 1 minute and 1.5 hours after testing paradigm ]
    A narrowband noise (from 2-12 kHz) is presented to the tinnitus ear and the minimum sound level (in decibel sound pressure level, decibel SPL) is determined that completely masks the tinnitus percept.


Secondary Outcome Measures :
  1. Change in Tinnitus Handicap Inventory Questionnaire Score [ Time Frame: Change from baseline score at 1 week after testing paradigm ]
    A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score.

  2. Change in Tinnitus Rating (0-10, 10 being worst) [ Time Frame: Change in baseline rating at an expected average of 4 minutes and 1.5 hours after testing paradigm ]
    The subject rates the disturbance or bothering nature of the tinnitus.

  3. Change in Tinnitus Subjective Description [ Time Frame: Change in baseline description at an expected average of 5 minutes and 1.5 hours after testing paradigm ]
    The subject describes the quality, characteristics and bothering nature of the tinnitus.

  4. Change in Tinnitus Matching (pitch and loudness) [ Time Frame: Change in baseline pitch and loudness at an expected average of 1.5 hours after testing paradigm ]
    The subject adjusts the loudness and pitch (i.e., frequency) of a sound played to an ear to that of the tinnitus percept.

  5. Daily Tinnitus Journal Entries [ Time Frame: 0, 1, 2, 3, 4, 5, 6, 7 days post-testing paradigm ]
    The subject describes the quality, characteristics and bothering nature of the tinnitus on a daily basis. The subject can also include any unusual or interesting events relating to the tinnitus that he/she feels would be relevant for the study.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Have subjective, non-pulsatile, and bothersome tinnitus
  • Will not start any new tinnitus treatment during the study
  • Ability to give informed consent and understand study objectives in English
  • Willing and able to understand and comply with all study-related procedures

Exclusion Criteria:

  • Substantial hearing loss or hyperacusis that may interfere with the study
  • Medical history of other ear or brain disorders, history of seizures, or currently using any medication or treatments that can cause or increase the chances of seizures
  • Any implanted medical or metal device, such as a pacemaker, aneurysm clip, or cochlear implant
  • Pregnant or currently breast-feeding (we need to give all female subjects a pregnancy test because pregnant females and unborn children need extra protection for their safety)
  • Any handicap that prevents the subject from reliably performing the tests

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02283216


Locations
Layout table for location information
United States, Minnesota
Nils Hasselmo Hall, 6-105
Minneapolis, Minnesota, United States, 55455
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Investigators
Layout table for investigator information
Principal Investigator: Hubert Lim, PhD University of Minnesota - Clinical and Translational Science Institute

Layout table for additonal information
Responsible Party: University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier: NCT02283216     History of Changes
Other Study ID Numbers: 1409M53708
First Posted: November 5, 2014    Key Record Dates
Last Update Posted: May 1, 2019
Last Verified: April 2019

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
neuromodulation
noninvasive
plasticity
transcranial magnetic stimulation
hearing
hyperacusis

Additional relevant MeSH terms:
Layout table for MeSH terms
Tinnitus
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms